Please ensure Javascript is enabled for purposes of website accessibility

Curaleaf Closes Long-Simmering Select Acquisition

By Eric Volkman - Feb 3, 2020 at 2:24PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The deal was originally announced in May 2019.

Big changes are afoot at Curaleaf (CURLF 1.24%) now that the company has closed a major acquisition.

Management announced Monday morning that the deal for Cura Partners, originally announced in May 2019, had finally closed on Saturday. Cura Partners' key asset is the Select cannabis brand.

When the transaction was originally announced, it was valued at roughly $949 million in the form of 95.5 million subordinate voting shares (SVS) of Curaleaf stock. The terms were subsequently amended to an upfront payment of around $286 million for 55 million of those shares, with the remaining shares coming in the form of incentive bonuses.

Marijuana bud with smoke behind it.

Image source: Getty Images

It seems Curaleaf believes that absorbing Cura Partners was worth the long wait. "With the completion of the acquisition, Curaleaf solidifies its stance as the largest cannabis operator in the U.S. in terms of operational and wholesale footprint," it said in its press release announcing the news.

The deal will also transform the company's managerial structure. Among other reshuffles and adjustments, it has created a chief marketing officer position, which will be filled by Select brand expert Jason White.

Meanwhile, Curaleaf Chief Financial Officer Neil Davidson has, effective immediately, become the chief operating officer. He displaces current COO Stuart Wilcox, who will "transition to a new role" that was not specified.

The CFO post is being filled by Michael Carlotti, who formerly occupied the same position at cannabis-focused Australis Capital.

Investors didn't seem particularly relieved that Curaleaf, a well-known marijuana stock, had finally tied up the loose ends of this transaction. Curaleaf shares were down about 3.5% in mid-afternoon trading Monday.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Curaleaf Holdings, Inc. Stock Quote
Curaleaf Holdings, Inc.
$6.05 (1.24%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.